Question 1

What is BioMarin Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

BioMarin Pharmaceuticals (BMRN) reported deferred tax assets and other non-current assets of $338.14M in Q2 2026.

Question 2

How has BioMarin Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

BioMarin Pharmaceuticals's deferred tax assets and other non-current assets increased by 35.7% year-over-year, from $249.19M to $338.14M.

Question 3

What is the long-term trend for BioMarin Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 14.3% compound annual growth rate (CAGR), from $142.24M to $277.05M.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

ASSETS	June 30, 2026 / (unaudited)	December 31, 2025 ⁽¹⁾
Intangible assets, net	4,879,367	213,837
Goodwill	655,745	196,199
Deferred tax assets	888,575	1,508,697
Other assets	338,138	277,049
Total assets	$11,723,442	$7,594,022
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$1,005,793	$759,031

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about BioMarin Pharmaceuticals's deferred tax assets and other non-current assets.

BioMarin Pharmaceuticals BMRN Deferred Tax Assets and Other Non-Current Assets